help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gibson, M. J.
Right arrow Articles by Dobrjansky, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibson, M. J.
Right arrow Articles by Dobrjansky, A.
Endocrinology Vol. 141, No. 9 3065-3071
Copyright © 2000 by The Endocrine Society


ARTICLES

Soluble Factors Guide Gonadotropin-Releasing Hormone Axonal Targeting to the Median Eminence1

Marie J. Gibson, Latanya Ingraham and Areta Dobrjansky

Division of Endocrinology and Metabolism, Mount Sinai School of Medicine, New York, New York 10029

Address all correspondence and requests for reprints to: Dr. Marie J. Gibson, 19530 Mammoth Drive, Bend, Oregon 97702. E-mail: jpgmjg{at}bendcable.com


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Axons of GnRH neurons terminate at the median eminence in the medial basal hypothalamus (MBH) of the brain early in development. Similarly, GnRH neurons in grafts of preoptic area (POA) tissue within the third ventricle of hypogonadal mice preferentially innervate the median eminence. Organotypic cocultures of POA explants with other neural tissues suggest that a soluble substance(s) derived from the MBH may be directing this targeting. To begin to identify diffusable chemoattractants, we used preincubated heparin-coated acrylic beads to present specific solutes to POA explants on collagen- and laminin-coated membranes in insert chambers. GnRH axons grew on the membrane in greater number and with longer axons toward conditioned medium from MBH cultures than on the side away from the beads (P < 0.01). In contrast, GnRH axons showed no preferential outgrowth when incubated with beads soaked in control, defined medium. The attraction of MBH-conditioned medium was not generalizable to all neuroendocrine neurons, as it was not seen for galanin immunoreactive outgrowth from POA explants. There also were more GnRH axons toward conditioned medium from mouse brain microvascular endothelial cells, but no difference in axon length. Basic fibroblast growth factor (bFGF), a component of both endothelial cells and ventricular tanycytes, significantly attracted more and longer GnRH axons. Thus, bFGF may be one of the soluble factors directing GnRH outgrowth to the median eminence. However, as with so many other redundancies in the reproductive system, it is unlikely that it is the only targeting factor, as bFGF knockout mice are reported to be reproductively competent.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
REPRODUCTIVE FUNCTION in mammals depends on appropriate targeting of GnRH axons to the median eminence of the brain. There the neuronal decapeptide is released into fenestrated capillaries of the pituitary-portal plexus and transported to gonadotrophs of the anterior pituitary to stimulate production and secretion of LH and FSH. Originating in the olfactory placode, GnRH cells migrate across the nasal septum into the brain by embryonic day 13 (E13) in the mouse (1, 2), and GnRH axons innervate the median eminence as early as E14 (3). The necessity for GnRH activity is seen in the hypogonadal mouse that lacks any gonadal development after birth due to a deletion in the GnRH gene (4, 5). Transplantation of fetal preoptic area tissue (POA) containing GnRH neurons into the third ventricle of adult hypogonadal mice stimulates reproductive function (6) when there is innervation of the host’s median eminence by the grafted GnRH neurons. If POA grafts are located far from the median eminence, neither innervation by GnRH axons nor gonadal development occurs (7, 8). In contrast, third ventricular implantation of grafts derived from accessory olfactory bulb, where GnRH neurons do not usually target the median eminence, results in GnRH fiber outgrowth to the median eminence and stimulation of reproductive development (9). GnRH neurons in POA grafts placed in the mammillary bodies, a site close to the median eminence but where GnRH neurons are not found in the mouse, also send fibers to the median eminence (10).

Cografts of fetal pituitaries with POA into the third ventricle of hypogonadal mice result in GnRH fibers growing into the gland, in addition to median eminence innervation (11). The finding that grafted GnRH neurons innervate the median eminence of hypophysectomized hosts indicates that the anterior pituitary is not an essential source of attractive factor(s). Indeed, in cografts of POA and fetal medial basal hypothalamus (MBH), a mini median eminence was formed within the graft, with robust GnRH innervation and GnRH axons terminating near fenestrated capillaries. To further study this apparent targeting, we used coexplants of fetal or neonatal POA with MBH, cerebellum, or spinal cord on collagen- and laminin-coated membranes in insert chambers (12). More and longer GnRH fibers grew out upon the membrane from the POA explant only toward MBH coexplants as early as 4 days and was maintained through 10 days of culture. These results were not due to trophic influences on the survival of GnRH neurons or fibers, as there were no differences in total numbers of GnRH cells within the cultures regardless of the nature of the coexplants, nor were there differences in the total numbers of GnRH axons growing out upon the membranes. Rather, the findings strongly suggest that diffusable chemoattractive signals for GnRH neurons are derived from the MBH.

The present studies were designed to establish that the MBH is a source of a soluble chemoattractant(s) to GnRH outgrowth while excluding possible cellular factors. We used presoaked heparin-coated acrylic beads anchored to the membrane in a drop of collagen and laminin to present putative targeting substances to the POA explant. First, we evaluated conditioned medium derived from MBH explants. As the fenestrated capillaries in the median eminence are the ultimate targets in the MBH, we also used beads presoaked in conditioned medium from mouse brain microvascular endothelial cells. In an initial effort to determine specific candidates for chemoattraction to the GnRH axons, we tested the efficacy of basic fibroblast growth factor (bFGF), an important component of both endothelial cells and ventricular tanycytes. The generality of the effect of MBH medium on other neuroendocrine cells was assessed by determining its effect on galanin fiber outgrowth.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Organotypic cocultures of POA explants with treated beads
All tissue explants were cultivated on the surface of the porous membranes of insert culture chambers (0.4-µm pore diameter and 12-mm diameter, cyclopore polyethylene terephthalate transparent membrane with 0.8 x 10 6 pores/cm2; Falcon/Becton Dickinson and Co., Franklin Lakes, NJ) as previously described (12). Briefly, the membranes were coated with a 9:1 mixture of rat tail collagen in 0.2% acetic acid (type I; 3 mg/ml; Sigma, St. Louis, MO) and laminin (100 µg/ml; Life Technologies, Inc., Gaithersburg, MD). The medium was DMEM and Ham’s nutrient mix F-12 with L-glutamine and 15 mM HEPES without phenol, supplemented with putrescine (10-4 M), sodium selenite (0.02 µg/ml), and apotransferrin (100 µg/ml; all medium ingredients from Sigma). This defined medium (DM) containing no serum, hormones, or antibiotics was used in all studies. The coated insert chamber membrane was washed with 200 µl DM before use.

Clusters of heparin-coated acrylic beads (Sigma) were incubated in a microfuge tube containing the test substance or control medium for 1–2 h. These beads have been used to present growth factors in studies of limb development in chick embryos (13). Approximately 3–5 µl of the collagen/laminin preparation were placed on the insert membrane, and a small cluster of the presoaked beads was placed in the drop and allowed to dry. Chambers were labeled sequentially, and experimental and control inserts were randomly placed. Codes for which chambers contained which types of beads were kept separately to permit blind analyses. POA tissue explants were then prepared as described below and placed immediately on the collagen- and laminin-coated surface of the insert chamber membrane at a small distance from the coated beads. All explants were kept moist by the addition of 10–20 µl DM above the membrane. The chambers were then placed in wells of 12- well plates containing 1 ml of the same medium. Cultures were incubated for 1 week at 37 C in 5% CO2 at 100% humidity. In all experiments, the medium was not changed, and care was taken to leave the cultures undisturbed until the time of fixation. The institutional animal care and use committee of the Mount Sinai School of Medicine approved all procedures.

Tissue collection
Newborn pups (C3H/HeHx101H) were collected less than 24 h after delivery (P1) and anesthetized by placement in culture dishes on ice before decapitation. The head was rinsed with a solution of 70% ethanol before dissection to assure sterility and was placed on a sterile stage under a binocular dissection microscope. The skull was removed, and the brain was inverted on the stage so that the ventral surface of the brain faced up. The POA was dissected under sterile conditions as described previously (14). When preparing MBH cultures for MBH-conditioned medium, the tissue including the median eminence was dissected as a midline strip from the ventral surface of the brain caudal to the POA. Tissue explants were placed immediately on the collagen- and laminin-coated surface of the insert chamber membrane.

Preparation of conditioned medium and specific factors
For MBH-conditioned medium (MBH-CM), three or four MBH explants obtained from P1 pups were placed on the coated surface of each membrane and covered with 100 µl DM. Each insert was placed in a well of a sterile 12-well plate containing 1 ml DM/well. Cultures were incubated for 1 week at 37 C in 5% CO2 at 100% humidity. Medium from the surface of an insert was aspirated and placed in a microfuge tube. The amount obtained was approximately 25 µl. An additional 100 µl DM were obtained from the well, used to rinse the membrane, and added to the microfuge tube. Each collection consisted of medium from three to six chambers. After collection, the MBH-conditioned medium was freed of any cellular matter, sterilized by filtering through a 0.2-µm pore size filter, and placed in a sterile tube before freezing at -20 C. DM was used as control. For endothelial cell-conditioned medium, mouse brain microvascular endothelial cells (MVEC; Cell Applications, Inc., San Diego, CA) were subcultured with MVEC growth medium, trypsinized, and replated with the DM described above, containing no serum, hormones, or antibiotics. After 3 days of incubation, the endothelial cell-conditioned medium was collected, freed of cellular material, and sterilized with a 0.2-µm pore size filter, and aliquots were frozen at -20 C. DM was used as a control. A product of endothelial cells, bFGF, has been implicated in regulating GnRH secretion. Beads were soaked in an aliquot containing 1 µg bFGF (recombinant human bFGF, Oncogene Research Products, Cambridge, MA) or DM.

Immunocytochemistry
After 7 days of incubation, the cultures were fixed by immersion in 4% paraformaldehyde for 3 h. All fixed cultures were kept at 4 C in phosphate buffer (0.1 M; pH 7.3) with 0.1% sodium azide (Sigma) until they were processed. Immunocytochemistry was performed directly on membranes after cutting them out of the chamber. To detect GnRH neurons and processes, SW1 antiserum (15) was used at a dilution of 1:2500 in PB containing 0.1% Triton X-100 (Sigma), 1% normal goat serum (Life Technologies, Inc.) or 3% normal donkey serum (NDS) (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) for 4 days at 4 C. We previously showed that preabsorption of the antiserum with 10 µg GnRH peptide eliminated reaction product in cells and fibers. The biotinylated antirabbit secondary antiserum (1:200 made in donkeys; Jackson ImmunoResearch Laboratories, Inc.) in the same diluent was applied overnight for increased penetration of the explants. Explants were then incubated in an avidin-biotin solution (Vector Laboratories, Inc., Burlingame, CA) conjugated with horseradish peroxidase for 2 h. The chromogen was 1 mg/ml 3,3'-diaminobenzidine (Sigma) and the H2O2 was generated by the oxidation of glucose by glucose oxidase (Sigma). To determine whether MBH-conditioned medium affected the outgrowth of another neuroendocrine peptide, other POA cultures were processed for galanin immunoreactivity using an antigalanin antibody raised in rabbits (Peninsula Laboratories, Inc., Belmont, CA; 1:4000). No immunoreactivity was detected when the antibody (1 ml) was preincubated with 200 µg synthetic galanin. The antibody was diluted as for the SW-1 used for GnRH as described above, and the cultures were similarly incubated, processed, and analyzed.

Immunocytochemistry was performed to detect the presence of bFGF in tanycytes in the mouse brain. Male mice deeply anesthetized with chloral hydrate (700 mg/kg, ip) were perfused with saline followed by 4% paraformaldehyde. Brains were removed and postfixed overnight, and coronal sections, 50 µm thick, were obtained with a Vibratome (Vibratome, Inc., St. Louis, MO). The sections were washed and incubated for 72 h with a dilute anti-bFGF antibody (raised in rabbits; Chemicon International, Inc., Temecula, CA) in 0.1 M PBS (1:1000) containing 1.5% NDS and 0.3% Triton X). After washing, bFGF was visualized using a mixture of 3,3'-diaminobenzidine and 0.005% H2O2 after incubation of the sections with 0.5% donkey antirabbit biotinylated antibody (Jackson ImmunoResearch Laboratories, Inc.) for 3 h and avidin biotin peroxidase solution (Vector Laboratories, Inc.) for 1 h. After washing, the sections were then incubated for 72 h in a dilute (1:1000 in 0.1 M PBS containing 1.5% NDS and 0.3% Triton X) antivimentin antibody (mouse monoclonal V2258, Sigma). In control sections for either bFGF or vimentin, there was no staining if the primary antibody was deleted. The sections were then washed, mounted onto gelatin-coated slides, coverslipped using Gelmount mounting medium (Biomedia, Foster City, CA), and analyzed under a light and fluorescent microscope (AX70, Olympus Corp., Melville, NY).

Analyses
Cultures were not considered for quantitative analysis if the explants fused with the beads or if there were less than 50 GnRH-immunoreactive (GnRH-ir) cell bodies in the POA. There are proposed spatial limits on guidance of 1 mm for target-derived diffusable substances and 1 cm for a substrate-bound gradient (16). We did not exclude cultures on the basis of distance between the culture and the cluster of beads, however, as the possibility remains that a diffusable substance may interact with elements in the substrate. GnRH axons extending on the surface of the membrane from the POA explant were counted on the side facing the cluster of beads and on the side away from the beads. It should be noted that fiber length only refers to distance from the edge of the explant and does not account for the variable locations of GnRH neurons within the explants.

The data were analyzed using statistical software (GBSTAT, Dynamic Microsystems, Inc.). All values were expressed as the mean ± SEM. When homogeneity of variances was not achieved, the appropriate transformation of the data were applied. The number of GnRH axons on the membranes toward and away from the beads was compared between treatment and control cultures using two-way ANOVA. When P < 0.05, Fisher’s least significant difference was used for post-hoc comparisons. The maximum extent reached by GnRH axonal outgrowth from the POA explant was also assessed. The three longest extending GnRH axons from the POA explant were measured in each sector with the help of a micrometer grid inserted in the eye piece of an Olympus Corp. BH-2 light microscope as described by Lumsden and Davies (17). The measurements were defined as follows. The zero reference bar of the grid was placed tangentially to the interface between the POA explant and membrane. The maximum distance reached on the membrane by the growth cone of the three farthest extending GnRH axons was measured regardless of the winding path of the axon. These three lengths were averaged for the sides toward and away from the beads. Due to the nature of the data, the maximum axonal extent was analyzed using nonparametric tests; Kruskal-Wallis ANOVA was used to compare multiple groups. Comparisons between the sides toward and away were analyzed using Wilcoxon signed rank test. Analysis for trophic effects on GnRH cell survival was performed by counting the number of GnRH cell bodies in the POA in the presence of treated or control beads. Comparing total GnRH axonal outgrowth between the groups using a t test assessed possible trophic effects on GnRH axonal outgrowth. The cultures were all coded before analysis so that the type of bead was unknown at the time of counting (e.g. they were counted blind).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Observations of the organotypic cultures in insert chambers
Consistent with our previous report, the explants survived well in culture. Despite the thickness of the whole mount preparation, GnRH-ir cells and fibers were clearly evident in the explants, showing morphology similar to that seen in vivo (Fig. 1AGo). As before, the explants tended to flatten during the culture period, resulting in varying distances between the edge of the culture and the cluster of beads (Table 1Go). GnRH fibers could also be followed as they exited the explants onto the surface of the insert chamber membrane (Fig. 1BGo), where growth cones were often discernible. The cluster of beads (Fig. 1CGo) was easily visualized, and occasionally fibers approached the cluster (Fig. 1DGo).



View larger version (88K):
[in this window]
[in a new window]
 
Figure 1. GnRH cells and fibers present in POA explants in insert chambers with clusters of presoaked acrylic beads. a, GnRH cells and fibers within a POA explant have a morphology similar to that in brain. b, GnRH fibers are seen exiting the explant onto the surface of the insert’s membrane. c, A cluster of heparin-coated acrylic beads fixed in a drop of collagen and laminin on the surface of the membrane. d, An occasional GnRH fiber traveled across the membrane to approach the cluster of beads. Scale bar, 20 µm in plates a and d and 40 µm in b and c.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Effect of treatment on GnRH cell survival and fiber outgrowth

 
Effect of MBH-conditioned medium
Significantly more GnRH fibers grew out upon the membrane toward beads presoaked in MBH-CM than away from the beads (P < 0.01; Fig. 2Go, upper panel). All but 1 of the 18 explants had more GnRH fibers toward the MBH-CM beads ({chi}2 = 14.2; P < 0.01). GnRH fibers also extended farther upon the membrane toward the MBH-CM beads than on the side away (P < 0.01). In 15 of the 18 cultures, the longest GnRH fibers were toward the MBH-CM beads ({chi}2 = 8; P < 0.01). In contrast, similar numbers and lengths of GnRH fibers grew on each side of the control POA explants (n = 12) that were cocultured with DM (see Fig. 2Go). In just 4 of the 12 control cultures there were more fibers toward the beads; in 6 the longest fibers were toward, and in 6 they were away. There was no difference in the distance between the POA and the cluster of beads between the 2 groups (Table 1Go). Conditioned medium derived from the MBH did not have a trophic influence on GnRH survival or axonal outgrowth. The numbers of GnRH-ir cells within the POA explants were similar whether cocultured with beads presoaked in MBH-CM or in DM, as were the total numbers of GnRH-ir fibers growing out upon the membrane (Table 1Go).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 2. The number and length of GnRH axons in POA explants growing toward ({square}) or away from ({blacksquare}) the cluster of beads presoaked in MBH-CM or control DM. Upper panel, Significantly more GnRH fibers grew toward the MBH-CM beads than away from them (P < 0.0l). Similar numbers of GnRH fibers grew toward as away from the control beads. Lower panel, The GnRH fibers growing toward the MBH-CM beads were significantly longer (P < 0.01) than those growing on the side away, whereas there was no significant difference in the length of the fibers exiting the POA explants in the presence of control beads.

 
In contrast to GnRH fiber outgrowth, galanin-ir fibers were not attracted toward beads presoaked in MBH-CM. Rather, there was a tendency for fewer fibers to grow toward the beads (n = 14; 49.0 ± 11.1) than away from the beads (68.6 ± 14.4). There was also no difference in control explants (n = 6; toward, 36.8 ± 11.1; away, 31.0 ± 6.9). Although the total number of galanin-ir fibers was somewhat higher in cultures with MBH-CM beads (117.6 ± 21.8) than in those with DM beads (67.8 ± 17.2), this did not reach significance (P > 0.10). The longest galanin-ir fibers toward the MBH-CM beads (371.2 ± 69.2) were similar to those on the side away (403.4 ± 69.5) as were those growing toward (281.1 ± 91.9) or away from (269.7 ± 70.6) the control beads.

Effect of MVEC-CM
More GnRH-ir fibers grew toward the MVEC-CM beads than grew either on the side away from the MVEC-CM beads or on the side away from the control beads (P < 0.05; Fig. 3Go, upper panel). The difference in outgrowth was not significant within the control cultures (P > 0.10). A large proportion (17 of 24; {chi}2 = 10.4; P < 0.01) of these POA cultures had more fibers growing toward the MVEC-CM beads. In contrast, the proportion of the control cultures with more GnRH fibers growing toward the beads was just 8 of 18 (not significant). In neither group were there differences in the length of fiber outgrowth (Fig. 3Go, lower panel).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 3. The number and length of GnRH axons in POA explants growing toward ({square}) or away from ({blacksquare}) the cluster of beads presoaked in MVEC-CM or control DM. Upper panel, Significantly more GnRH fibers grew toward the MVEC-CM beads than away from them or than the number of GnRH fibers growing on the side away from the control beads (P < 0.05). Lower panel, The length of the GnRH-ir fibers was similar on either side of the explants cocultured with beads presoaked with either MVEC-CM or control DM.

 
Effect of bFGF
Beads presoaked in bFGF were an attractive target. More GnRH fibers grew toward the bFGF beads. The number of GnRH fibers on the side away from the bFGF beads was also less than that on the side growing toward the control beads (P < 0.01; Fig. 4Go, upper panel). Of 15 explants cocultured with bFGF-soaked beads, 13 had more GnRH-ir fibers on the side growing toward the beads ({chi}2 =8.1; P < 0.01). The mean length of the 3 longest fibers was significantly less on the side away from the bFGF beads than on the sides toward the bFGF beads or the control beads (P < 0.05; Fig. 4Go, lower panel). The proportion (11 of 15) of the explants with longer fibers toward the bFGF beads was not significant. The number and length of GnRH-ir fibers on the membrane were similar on each side of the control cultures. The tendency for the total number of GnRH fibers to be lower in cultures in the presence of bFGF did not reach significance (P > 0.06; Table 1Go).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 4. The number and length of GnRH axons in POA explants growing toward ({square}) or away from ({blacksquare}) the cluster of beads presoaked in bFGF or control medium. Upper panel, Significantly more GnRH fibers grew toward the bFGF or the control beads than on the side away from the bFGF beads (P < 0.01). Lower panel, GnRH fibers grew significantly longer toward the bFGF beads or the control beads than on the side away from the bFGF beads (P < 0.05). The number and length of GnRH fibers were similar on each side of the control cultures.

 
The presence of bFGF in tanycytes as well as in the external layer of the median eminence in the mouse brain was confirmed by double label immunocytochemistry with vimentin labeling to identify tanycytes (Fig. 5Go). In previous work (18) we visualized a larger population of tanycytes, perhaps due to the different antibody for vimentin employed here. From the pattern of bFGF labeling it is likely that bFGF is present in only a portion of the tanycytes in the median eminence.



View larger version (96K):
[in this window]
[in a new window]
 
Figure 5. Micrographs of the lateral portion of the median eminence in an adult male mouse. Distribution of bFGF immunoreactivity is seen in the upper panel, and vimentin immunoreactivity in the same section is shown in the lower panel. Note that bFGF is evident in the tanycyte (arrow), identified by vimentin labeling. Scale bar, 50 µm.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The use of acrylic beads to present conditioned medium or selected factors to the POA organotypic explant confirmed that diffusable substances emanating from the MBH are attractive to GnRH axonal outgrowth. Although our previous work with organotypic cocultures of POA and MBH strongly suggested this, in that study we were unable to exclude the role of cellular elements. The success of this system, using stringent medium, demonstrates that specific solutes may now be tested for both their trophic (enhancing cell survival and projections) and tropic (directing directionality of axonal projections) activities. In the present studies none of the substances tested appeared to have a trophic influence on the total numbers of surviving GnRH-ir cells or fibers growing out upon the membrane. Particularly for the POA cultures with MBH-conditioned medium, this is consistent with the previous findings regarding MBH coexplants where there were also no significant trophic effects (12). In contrast, the present studies provided clear indications of tropic, chemoattractive activities for the GnRH fiber projections. This was evident not only with the conditioned medium from neonatal MBH, but also, to a lesser degree, with the conditioned medium from the mouse brain MVEC. There was also an effect seen with bFGF, which is present in endothelial cells and at least some of the tanycytes in the median eminence of the mouse. The tropic effect of bFGF appeared robust on a within-culture basis. Compared with the control cultures in the same experiment, however, the lower overall number of GnRH fibers growing out with bFGF beads may indicate that other factors are involved. The attractiveness of the MBH medium for GnRH axons was not generalizable, as galanin-ir cells sent similar numbers of projections toward and away from the presoaked beads.

The MBH region contains the median eminence, the ultimate target of GnRH axons in normal development and also of GnRH fibers emerging from third ventricular POA grafts in hypogonadal mice. In both cases GnRH fibers terminate upon the fenestrated capillaries in the median eminence. We hypothesized that the endothelial cells in these capillaries contain a chemoattractive factor(s) for GnRH axons. The results with conditioned medium from the cultured mouse brain MVEC supported this hypothesis, but were not impressive. The mouse brain endothelial cells may have been an imperfect model for the endothelial cells in the capillaries of the median eminence, as the latter are fenestrated, in contrast to those in most neural vasculature. Recent findings indicate considerable heterogeneity among endothelial cells from different sources as well as changes in characteristics due to culture conditions (19).

In earlier work we discussed the role of tanycytes in GnRH neuronal guidance at the median eminence and noted that we did not always see close associations (18). At that time we speculated that although tanycytes may provide a permissive substrate for GnRH axonal extension, they do not fully explain the precise targeting seen, but perhaps tanycytes play a role not just in physical guidance by possible adhesion factors, but also by the presence of guidance factors such as bFGF in at least a portion of them. Kozlowski and Coates (20) described the close contact of GnRH fibers with basal processes of tanycytes, often within ependymal canaliculi formed by adjacent ependymal cells and also containing unidentified axons. We showed that when GnRH axons grow out upon the membrane from POA explants, they are not usually associated with tanycytes, but always travel with growth associated protein (GAP-43)-labeled axons (12). Within the MBH coexplants, however, GnRH axons projected to a region resembling the median eminence, as visualized by vimentin-ir tanycytes. Tanycytes are also implicated in regeneration of monoaminergic axons in the MBH (21).

The use of heparin-coated beads may have enhanced the effectiveness of bFGF, as it is a member of the family of heparin-binding growth factors. Widely distributed during embryonic development (22) and in neuronal and glial cells in the adult rodent brain (23, 24), bFGF is also present in the ependymal cells that line the third ventricle (25) and in endothelial cells (26, 27). Many structures in the rat hypothalamus contain the messenger RNA for the bFGF receptor, FGFR1 (24). This receptor contains a cell adhesion molecule domain that is implicated in neurite outgrowth (reviewed in Ref. 28). FGF activity also involves the extracellular signaling molecules heparan sulfate proteoglycans, and there is the possibility that the activity may sometimes involve a ternary complex of heparan sulfate proteoglycan, FGF, and the FGF receptor (28). Nevertheless, the mechanism of bFGF release remains unclear, because it lacks a signaling domain.

Survival and neurite outgrowth is promoted by bFGF in GT1 cells, the immortalized GnRH neuronal cell line (29, 30). The growth factor is also involved in processing pro-GnRH to decapeptide in GT1 cells (31). FGFR-1 receptors are present on GT1–7 cells (32), whereas it is difficult to detect these receptors on GnRH neurons. As explants dissected on P1 were used in the present study, it is highly likely that most GnRH axons growing out upon the membrane are regenerating. As in our previous work with both E15 and P1 POA explants (12), growth cones were often evident (not shown). In primary cultures, fetal GnRH neurons also respond to bFGF with neurite outgrowth (33). The present study further demonstrates that such outgrowth may be directed by bFGF to the appropriate target for neuroendocrine activity.

Galanin is another neuropeptide implicated in neuroendocrine function (34). The majority of galanin cells that project to the median eminence in the rat are located in the arcuate nucleus, as determined by uptake of peripherally administered fluorogold, with most of the others found in the paraventricular nucleus (35). In the mouse, however, very few galanin-ir cells in the arcuate nucleus have projections to the median eminence (36), whereas a large proportion of galanin neurons in the nucleus circularis, supraoptic nucleus, and paraventricular nucleus have such projections. The POA explants undoubtedly include at least the nucleus circularis. The large numbers of galanin-ir fibers seen here support that a substantial population of galanin neurons was present in the POA explants. Although one may argue that many of these neurons do not usually target the median eminence, the lack of effect of the MBH-conditioned medium on galanin fiber outgrowth is in striking contrast to the effect on GnRH neurons. As discussed above, even GnRH neurons obtained from the accessory olfactory bulb will target the median eminence from intraventricular grafts (9). The fact that galanin is often colocalized in GnRH neurons in the mouse (37), as in other species (38, 39), dramatizes the difference in control of axonal targeting. The present studies did not address whether MBH-conditioned medium preferentially attracts the axons of the subset of galanin neurons that colocalize GnRH. As they constitute a fraction of the total galanin neurons, it seems that even if the GnRH-containing fibers were attracted, it would be unlikely to significantly affect the total galanin-ir outgrowth measured here.

In our studies with hypogonadal mice we have shown that there is enormous redundancy in the reproductive system. The most remarkable example is the fact that a hypogonadal mouse may conceive and bear young with only one detectable GnRH neuron in the third ventricular graft as long as there is GnRH axonal innervation of the median eminence (6). Thus, although the work reported here indicates a role for bFGF in directing the outgrowth of GnRH projections, it is likely not unique. Consistent with this conclusion is the observation that the bFGF knockout mouse is fertile and not grossly phenotypically different from wild-type animal despite differences in neocortical architecture that suggest a role in neurogenesis (23, 40, 41). In light of the powerful need for reproductive success in conservation of species, these redundancies are not surprising. Another consideration in interpreting the results of the present studies is that there is a precedent for growth factors to act in concert. The model used here should be valuable in identifying other chemoattractive substances that direct GnRH targeting.


    Acknowledgments
 
We thank Dr. Gopalan Rajendren for his assistance with photography and advice with regard to the immunocytochemistry. Dr. Susan Wray generously provided the SW1 anti-GnRH antiserum.


    Footnotes
 
1 This work was supported by NIH Grant NS-20335. Back

Received February 14, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Wray S, Grant P, Gainer H 1989 Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc Natl Acad Sci USA 86:8132–8136[Abstract/Free Full Text]
  2. Schwanzel-Fukuda M, Pfaff DW 1989 Origin of luteinizing hormone releasing hormone neurons. Nature 333:161–164[CrossRef]
  3. Livne I, Gibson MJ, Silverman A-J 1993 Biochemical differentiation and intercellular interactions of migratory gonadotropin-releasing hormone (GnRH) cells in the mouse. Dev Biol 159:643–656[CrossRef][Medline]
  4. Cattanach BM, Iddon CA, Charlton HM, Chiappa SA, Fink G 1977 Gonadotropin releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 269:338–340[CrossRef][Medline]
  5. Mason AJ, Hayflick JS, Zoeller RT, Young WS, III, Phillips HS, Nikolics K, Seeburg PH 1986 A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 234:1366–1371[Abstract/Free Full Text]
  6. Gibson MJ, Krieger DT, Charlton HM, Zimmerman EA, Silverman AJ, Perlow MJ 1984 Mating and pregnancy can occur in genetically hypogonadal mice with preoptic area brain grafts. Science 225:949–951[Abstract/Free Full Text]
  7. Kokoris GJ, Silverman AJ, Zimmerman EA, Perlow MJ, Gibson MJ 1987 Implantation of fetal preoptic area into the lateral ventricle of adult hypogonadal (hpg) mutant mice: The pattern of gonadotropin-releasing hormone GnRH axonal outgrowth into the host brain. Neuroscience 22:159–167[CrossRef][Medline]
  8. Rajendren G, Gibson MJ 1998 Comparison of afferent and efferent competence of transplanted GnRH cells in the brains of hypogonadal female mice. J Neuroendocrinol 10:249–257[CrossRef][Medline]
  9. Perlow MJ, Kokoris GJ, Gibson MJ, Silverman AJ, Krieger DT, Zimmerman EA 1987 Accessory olfactory bulb transplants correct hypogonadism in mutant mice. Brain Res 415:158–162[CrossRef][Medline]
  10. Rogers M-C, Silverman A-J, Gibson MJ 1998 Preoptic area grafts implanted in mammillary bodies of hypogonadal mice: patterns of GnRH neuronal projections. Exp Neurol 151:265–272[CrossRef][Medline]
  11. Saitoh Y, Gibson MJ, Silverman A-J 1992 Targeting of gonadotropin-releasing hormone axons from preoptic area grafts to the median eminence. J Neurosci Res 33:379–391[CrossRef][Medline]
  12. Rogers M-C, Silverman A-J, Gibson MJ 1997 Gonadotropin-releasing hormone axons target the median eminence: in vitro evidence for diffusible chemoattractive signals from the mediobasal hypothalamus. Endocrinology 138:3956–3966[Abstract/Free Full Text]
  13. Cohn MJ, Izpisua-Belmonte JC, Abud H, Heath JK, Tickle C 1995 Fibroblast growth factors induce additional limb development from the flank of chick embryos. Cell 80:739–746[CrossRef][Medline]
  14. Krieger DT, Perlow MJ, Gibson MJ, Davies TF, Zimmerman EA, Ferin M, Charlton HM 1982 Brain grafts reverse hypogonadism of gonadotropin releasing hormone deficiency. Nature 298:468–471[CrossRef][Medline]
  15. Wray S, Gahwiler BH, Gainer H 1988 Slice cultures of LHRH neurons in the presence and absence of brainstem and pituitary. Peptides 9:1151–1175[CrossRef][Medline]
  16. Goodhill GJ 1998 Mathematical guidance for axons. Trends Neurosci 21:226–231[CrossRef][Medline]
  17. Lumsden AGS, Davies AM 1983 Earliest sensory fibres are guided to peripheral targets by attractants other than nerve growth factor. Nature 306:786–788[CrossRef][Medline]
  18. Silverman RC, Gibson MJ, Silverman AJ 1991 Relationship of glia to GnRH axonal outgrowth from third ventricular grafts in hpg hosts. Exp Neurol 114:259–274[CrossRef][Medline]
  19. Stins MF, Gilles F, Kim KS 1997 Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 76:81–90[CrossRef][Medline]
  20. Kozlowski GP, Coates PW 1985 Ependymoneuronal specializations between LHRH fibers and cells of the cerebroventricular system. Cell Tissue Res 242:301–311[Medline]
  21. Chauvet N, Prieto M, Alonso G 1998 Tanycytes present in the adult rat mediobasal hypothalamus support the regeneration of monoaminergic axons. Exp Neurol 151:1–13[CrossRef][Medline]
  22. Weise B, Janet T, Grothe C 1993 Localization of bFGF and FGF-receptor in the developing nervous system of the embryonic and newborn rat. J Neurosci Res 34:442–453[CrossRef][Medline]
  23. Fuxe K, Tinner B, Zoli M, Pettersson RF, Baird A, Biagini G, Chadi G, Agnati LF 1996 Computer-assisted mapping of basic fibroblast growth factor immunoreactive nerve cell populations in the rat brain. J Chem Neuroanat 11:13–35[CrossRef][Medline]
  24. Gonzalez AM, Berry M, Maher PA, Logan A, Baird A 1995 A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res 701:201–226[CrossRef][Medline]
  25. Cuevas P, Gimenez-Gallego G, Martinez-Murillo R, Carceller F 1991 Immunohistochemical localization of basic fibroblast growth factor in ependymal cells of the rat lateral and third ventricles. Acta Anat.( Basel) 141:307–310
  26. Weich HA, Iberg N, Klagsbrun M, Folkman J 1991 Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells. J Cell Biochem 47:158–164[CrossRef][Medline]
  27. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D 1987 Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325:257–259[CrossRef][Medline]
  28. Bikfalvi A, Klein S, Pintucci G, Rifkin DB 1997 Biological roles of fibroblast growth factor-2. Endocr Rev 18:26–45[Abstract/Free Full Text]
  29. Tsai P-S, Werner S, Weiner RI 1995 Basic fibroblast growth factor is a neurotropic factor in GT1 gonadotropin-releasing hormone neuronal cell lines. Endocrinology 136:3831–3838[Abstract]
  30. Ochoa A, Domenzain C, Clapp C, Martinez de la Escalera G 1997 Differential effects of basic fibroblast growth factor, epidermal growth factor, transforming growth factor-{alpha}, and insulin-like growth factor-I on a hypothalamic gonadotropin-releasing hormone neuronal cell line. J Neurosci Res 49:739–749[CrossRef][Medline]
  31. Wetsel WC, Hill DF, Ojeda SR 1996 Basic fibroblast growth factor regulates the conversion of pro-luteinizing hormone-releasing hormone (pro-LHRH) to LHRH in immortalized hypothalamic neurons. Endocrinology 137:2606–2616[Abstract]
  32. Voigt P, Ma YJ, Gonzalez D, Fahrenbach WH, Wetsel WC, Berg-von der Emde K, Hill DF, Taylor KG, Costa ME, Seidah NG, Ojeda SR 1996 Neural and glial-mediated effects of growth factors acting via tyrosine kinase receptors on luteinizing hormone-releasing hormone neurons. Endocrinology 137:2593–2605[Abstract]
  33. Ojeda SR, Urbanski HF, Costa ME, Hill DF, Moholt-Siebert M 1990 Involvement of transforming growth factor {alpha} in the release of luteinizing hormone-releasing hormone from the developing female hypothalamus. Proc Natl Acad Sci USA 87:9698–9702[Abstract/Free Full Text]
  34. Lopez FJ, Merchenthaler I, Ching M, Wisniewski MG, Negro-Vilar A 1991 Galanin: A hypothalamic-hypophysiotropic hormone modulating reproductive functions. Proc Natl Acad Sci USA 88:4508–4512[Abstract/Free Full Text]
  35. Merchenthaler I 1991 The hypophysiotropic galanin system of the rat brain. Neuroscience 44:643–654[CrossRef][Medline]
  36. Rajendren G, Levenkova N, Gibson MJ 2000 Galanin immunoreactivity in mouse basal forebrain: sex differences and discrete projections of galanin-containing cells beyond the blood-brain barrier. Neuroendocrinology 71:27–33[CrossRef][Medline]
  37. Rajendren G, Gibson MJ 1999 Expression of galanin immunoreactivity in gonadotropin-releasing hormone neurons in mice: a confocal microscopic study. Brain Res 821:270–276[CrossRef][Medline]
  38. Coen CW, Montagnese C, Opacka-Juffry J 1990 Coexistence of gonadotrophin-releasing hormone and galanin: immunohistochemical and functional studies. J Neuroendocrinol 2:107–111
  39. Merchenthaler I, Lopez FJ, Negro-Vilar A 1990 Colocalization of galanin and luteinizing hormone-releasing hormone in a subset of preoptic hypothalamic neurons: anatomical and functional correlates. Proc Natl Acad Sci USA 87:6326–6330[Abstract/Free Full Text]
  40. Vaccarino FM, Schwartz ML, Raballo R, Nilsen J, Rhee J, Zhou M, Doetschman T, Coffin JD, Wyland JJ, Hung Y-TE 1999 Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat Neurosci 2:246–253[CrossRef][Medline]
  41. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C 1998 Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci USA 95:5672–5677[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
EndocrinologyHome page
S. A. Tobet and G. A. Schwarting
Minireview: Recent Progress in Gonadotropin-Releasing Hormone Neuronal Migration
Endocrinology, March 1, 2006; 147(3): 1159 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. C. Gill and P.-S. Tsai
Expression of a Dominant Negative FGF Receptor in Developing GNRH1 Neurons Disrupts Axon Outgrowth and Targeting to the Median Eminence
Biol Reprod, March 1, 2006; 74(3): 463 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Pitteloud, J. S. Acierno Jr., A. U. Meysing, A. A. Dwyer, F. J. Hayes, and W. F. Crowley Jr.
Reversible Kallmann Syndrome, Delayed Puberty, and Isolated Anosmia Occurring in a Single Family with a Mutation in the Fibroblast Growth Factor Receptor 1 Gene
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1317 - 1322.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. P. Bless, H. J. Walker, K. W. Yu, J. G. Knoll, S. M. Moenter, G. A. Schwarting, and S. A. Tobet
Live View of Gonadotropin-Releasing Hormone Containing Neuron Migration
Endocrinology, January 1, 2005; 146(1): 463 - 468.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. C. Gill, S. M. Moenter, and P.-S. Tsai
Developmental Regulation of Gonadotropin-Releasing Hormone Neurons by Fibroblast Growth Factor Signaling
Endocrinology, August 1, 2004; 145(8): 3830 - 3839.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gibson, M. J.
Right arrow Articles by Dobrjansky, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibson, M. J.
Right arrow Articles by Dobrjansky, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals